Finance

Lists
ZVRA:NASDAQ
Zevra Therapeutics Inc
$ 11.35
+0.44%
(+0.050) 1D
9-р сарын 29, 11:01:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZVRA...
Open
$ 11.28
High
$ 11.40
Low
$ 11.20
Mkt. cap
674.01 сая
Avg. vol.
858.09 мян
Volume
79.46 мян
P/E ratio
11.85
52-wk high
$ 15.04
52-wk low
$ 8.01
EPS
$ 0.96
Beta
0.95
Shares outstanding
59.38 сая
No. of employees
61
Open
$ 11.28
High
$ 11.40
Low
$ 11.20
Mkt. cap
674.01 сая
Avg. vol.
858.09 мян
Volume
79.46 мян
P/E ratio
11.85
52-wk high
$ 15.04
52-wk low
$ 8.01
EPS
$ 0.96
Beta
0.95
Shares outstanding
59.38 сая
No. of employees
61
About Zevra Therapeutics Inc
CEO-
Employees61
Founded2006
Headquarters-
SectorPharmaceutical industry
Websitezevra.com
Analyst ratings
Based on 9 analysts giving stock ratings to ZVRA in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ZVRA in the last 3 months.
Highest
Current $ 11.35
$ 35.00 (+208.37%)
Average
$ 25.25 (+122.47%)
Lowest
$ 20.00 (+76.21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Maintained
$ 26.00
+129.1%
09/21/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
$ 20.00
+76.2%
08/11/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$ 35.00
+208.4%
08/06/2026
Eddie Hickman
Guggenheim
Buy
Maintained
$ 23.00
+102.6%
08/06/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$ 21.00
+85%
08/06/2026
Kambiz Yazdi
BTIG
Buy
Maintained
$ 24.00
+111.5%
08/05/2026
Jason Butler
Citizens JMP
Buy
Maintained
$ 28.00
+146.7%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$ 25.00
+120.3%
08/05/2026
Unknown Analyst
Roth MKM
Buy
Maintained
$ 21.00
+85%
05/07/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
03/16/2026
Last report
2026 оны 8-р сарын 5
Fiscal period
Q2 2026
EPS / Est. (USD)
$ 0.25 / $ 0.18
+41.51%beat
Revenue / Est. (USD)
39.66 сая / 34.84 сая
+13.85%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
26.06 сая
34.12 сая
36.22 сая
39.66 сая
Cost of goods sold
1.24 сая
1.52 сая
1.90 сая
1.52 сая
Cost of revenue
1.24 сая
1.52 сая
1.90 сая
1.52 сая
Research and development expenses
3.43 сая
2.52 сая
4.39 сая
4.49 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.94 сая
20.45 сая
20.78 сая
16.56 сая
Operating expense
20.68 сая
23.29 сая
25.49 сая
21.36 сая
Total operating expenses
21.92 сая
24.81 сая
27.39 сая
22.89 сая
Operating income
4.14 сая
9.32 сая
8.83 сая
16.78 сая
Other non operating income
-5.51 сая
3.56 сая
-6.25 сая
-6.41 сая
EBT including unusual items
-977.00 мян
12.67 сая
44.80 сая
12.79 сая
EBT excluding unusual items
-1.10 сая
12.64 сая
4.46 сая
12.93 сая
Income tax expense
-433.00 мян
501.00 мян
6.91 сая
4.04 сая
Effective tax rate
44.32%
3.96%
15.43%
31.59%
Other operating expenses
-
-
-
-
Net income
-544.00 мян
12.16 сая
37.89 сая
8.75 сая
Net profit margin
-2.09%
35.65%
104.61%
22.07%
Earnings per share
-0.01
0.19
0.18
0.25
Interest and investment income
2.31 сая
1.71 сая
3.59 сая
2.56 сая
Interest expense
-2.05 сая
-1.95 сая
-1.71 сая
-
Net interest expenses
262.00 мян
-236.00 мян
1.88 сая
2.56 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
4.54 сая
9.68 сая
9.20 сая
17.14 сая
Gain or loss from assets sale
-
63.00 мян
-43.31 сая
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс